These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 20380235)

  • 1. [Clinical experiences with agomelatine. The inner ear has to be synchronized again].
    MMW Fortschr Med; 2010 Mar; 152(10):46-7. PubMed ID: 20380235
    [No Abstract]   [Full Text] [Related]  

  • 2. Agomelatine: new drug. Adverse effects and no proven efficacy.
    Prescrire Int; 2009 Dec; 18(104):241-5. PubMed ID: 20020562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agomelatine treatment corrects impaired sleep-wake cycle and sleep architecture and increases MT
    Tchekalarova J; Kortenska L; Ivanova N; Atanasova M; Marinov P
    Psychopharmacology (Berl); 2020 Feb; 237(2):503-518. PubMed ID: 31720718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lights off? Neurobiological and pharmacological aspects of the melatonergic-serotonergic synergism].
    Sumegi A; Somoskovi C
    Neuropsychopharmacol Hung; 2010 Dec; 12(4):469-75. PubMed ID: 21220792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Modern approaches to the synchronization of circadian rhythms in treatment of depression].
    Barylnik JB; Filippova NV; Trayber LV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(11):124-8. PubMed ID: 25629135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Agomelatine: the first "melatoninergic" antidepressant].
    Bánki MC
    Neuropsychopharmacol Hung; 2006 Oct; 8(3):105-12. PubMed ID: 17211046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agomelatine versus other antidepressive agents for major depression.
    Guaiana G; Gupta S; Chiodo D; Davies SJ; Haederle K; Koesters M
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008851. PubMed ID: 24343836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a randomized, double-blind comparison with sertraline.
    Kasper S; Hajak G; Wulff K; Hoogendijk WJ; Montejo AL; Smeraldi E; Rybakowski JK; Quera-Salva MA; Wirz-Justice AM; Picarel-Blanchot F; Baylé FJ
    J Clin Psychiatry; 2010 Feb; 71(2):109-20. PubMed ID: 20193645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Depression as chronobiological illness].
    Kálmán J; Kálmán S
    Neuropsychopharmacol Hung; 2009 Jun; 11(2):69-81. PubMed ID: 19827314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bidirectional communication between sleep and circadian rhythms and its implications for depression: lessons from agomelatine.
    Pandi-Perumal SR; Moscovitch A; Srinivasan V; Spence DW; Cardinali DP; Brown GM
    Prog Neurobiol; 2009 Aug; 88(4):264-71. PubMed ID: 19454302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the novel antidepressant agomelatine on disturbed sleep-wake cycles in depressed patients.
    Quera-Salva MA; Lemoine P; Guilleminault C
    Hum Psychopharmacol; 2010 Apr; 25(3):222-9. PubMed ID: 20373473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agomelatine: a preliminary review of a new antidepressant.
    Zupancic M; Guilleminault C
    CNS Drugs; 2006; 20(12):981-92. PubMed ID: 17140278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond the monoaminergic hypothesis: agomelatine, a new antidepressant with an innovative mechanism of action.
    Kasper S; Hamon M
    World J Biol Psychiatry; 2009; 10(2):117-26. PubMed ID: 19255935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of obsessive-compulsive disorder successfully treated with agomelatine monotherapy.
    De Berardis D; Serroni N; Campanella D; Olivieri L; Moschetta FS; Conti CM; Conti P; Di Giannantonio M
    J Clin Psychopharmacol; 2012 Apr; 32(2):289-90. PubMed ID: 22388158
    [No Abstract]   [Full Text] [Related]  

  • 15. [Melatonin, melatonin receptor agonists and tryptophan as sleep aids].
    Steinhilber D
    Pharm Unserer Zeit; 2007; 36(3):213-7. PubMed ID: 17555058
    [No Abstract]   [Full Text] [Related]  

  • 16. Agomelatine: a novel mechanism of antidepressant action involving the melatonergic and the serotonergic system.
    San L; Arranz B
    Eur Psychiatry; 2008 Sep; 23(6):396-402. PubMed ID: 18583104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of the novel antidepressant and melatonin agonist/serotonin2C receptor antagonist, agomelatine, on the rat sleep-wake cycle architecture.
    Descamps A; Rousset C; Millan MJ; Spedding M; Delagrange P; Cespuglio R
    Psychopharmacology (Berl); 2009 Jul; 205(1):93-106. PubMed ID: 19370342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic agomelatine treatment corrects the abnormalities in the circadian rhythm of motor activity and sleep/wake cycle induced by prenatal restraint stress in adult rats.
    Mairesse J; Silletti V; Laloux C; Zuena AR; Giovine A; Consolazione M; van Camp G; Malagodi M; Gaetani S; Cianci S; Catalani A; Mennuni G; Mazzetta A; van Reeth O; Gabriel C; Mocaër E; Nicoletti F; Morley-Fletcher S; Maccari S
    Int J Neuropsychopharmacol; 2013 Mar; 16(2):323-38. PubMed ID: 22310059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agomelatine for depression: expanding the horizons?
    Norman TR; Olver JS
    Expert Opin Pharmacother; 2019 Apr; 20(6):647-656. PubMed ID: 30759026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agomelatine: innovative pharmacological approach in depression.
    Popoli M
    CNS Drugs; 2009; 23 Suppl 2():27-34. PubMed ID: 19708723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.